These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9255946)

  • 21. Design and synthesis of C-linked fucosides as inhibitors of E-selectin.
    Uchiyama T; Woltering TJ; Wong W; Lin CC; Kajimoto T; Takebayashi M; Weitz-Schmidt G; Asakura T; Noda M; Wong CH
    Bioorg Med Chem; 1996 Jul; 4(7):1149-65. PubMed ID: 8831987
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quinic acid derivatives as sialyl Lewis(x)-mimicking selectin inhibitors: design, synthesis, and crystal structure in complex with E-selectin.
    Kaila N; Somers WS; Thomas BE; Thakker P; Janz K; DeBernardo S; Tam S; Moore WJ; Yang R; Wrona W; Bedard PW; Crommie D; Keith JC; Tsao DH; Alvarez JC; Ni H; Marchese E; Patton JT; Magnani JL; Camphausen RT
    J Med Chem; 2005 Jun; 48(13):4346-57. PubMed ID: 15974587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Modulation of sialyl Lewis X dependent binding to E-selectin by glycoforms of alpha-1-acid glycoprotein expressed in rheumatoid arthritis.
    Jørgensen HG; Elliott MA; Priest R; Smith KD
    Biomed Chromatogr; 1998; 12(6):343-9. PubMed ID: 9861495
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Design and synthesis of sialyl Lewis(x) mimics as E- and P-selectin inhibitors.
    Kaila N; Thomas BE
    Med Res Rev; 2002 Nov; 22(6):566-601. PubMed ID: 12369089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. De novo expression of endothelial sialyl Lewis(a) and sialyl Lewis(x) during cardiac transplant rejection: superior capacity of a tetravalent sialyl Lewis(x) oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion.
    Turunen JP; Majuri ML; Seppo A; Tiisala S; Paavonen T; Miyasaka M; Lemström K; Penttilä L; Renkonen O; Renkonen R
    J Exp Med; 1995 Oct; 182(4):1133-41. PubMed ID: 7561686
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conformational dynamics of sialyl Lewisx in aqueous solution and its interaction with selectinE. A study by molecular dynamics.
    Veluraja K; Margulis CJ
    J Biomol Struct Dyn; 2005 Aug; 23(1):101-11. PubMed ID: 15918681
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Probing the carbohydrate recognition domain of E-selectin: the importance of the acid orientation in sLex mimetics.
    Titz A; Patton J; Smiesko M; Radic Z; Schwardt O; Magnani JL; Ernst B
    Bioorg Med Chem; 2010 Jan; 18(1):19-27. PubMed ID: 19948406
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Higher-affinity oligosaccharide ligands for E-selectin.
    Nelson RM; Dolich S; Aruffo A; Cecconi O; Bevilacqua MP
    J Clin Invest; 1993 Mar; 91(3):1157-66. PubMed ID: 7680663
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Binding free energy calculations on E-selectin complexes with sLe
    Barra PA; Ribeiro AJ; Ramos MJ; Jiménez VA; Alderete JB; Fernandes PA
    Chem Biol Drug Des; 2017 Jan; 89(1):114-123. PubMed ID: 27515911
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic glycopeptides from the E-selectin ligand 1 with varied sialyl Lewis(x) structure as cell-adhesion inhibitors of E-selectin.
    Filser C; Kowalczyk D; Jones C; Wild MK; Ipe U; Vestweber D; Kunz H
    Angew Chem Int Ed Engl; 2007; 46(12):2108-11. PubMed ID: 17295374
    [No Abstract]   [Full Text] [Related]  

  • 31. Transgene expression of alpha(1,2)-fucosyltransferase-I (FUT1) in tumor cells selectively inhibits sialyl-Lewis x expression and binding to E-selectin without affecting synthesis of sialyl-Lewis a or binding to P-selectin.
    Mathieu S; Prorok M; Benoliel AM; Uch R; Langlet C; Bongrand P; Gerolami R; El-Battari A
    Am J Pathol; 2004 Feb; 164(2):371-83. PubMed ID: 14742243
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The three members of the selectin receptor family recognize a common carbohydrate epitope, the sialyl Lewis(x) oligosaccharide.
    Foxall C; Watson SR; Dowbenko D; Fennie C; Lasky LA; Kiso M; Hasegawa A; Asa D; Brandley BK
    J Cell Biol; 1992 May; 117(4):895-902. PubMed ID: 1374413
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of protonation of the N-acetyl neuraminic acid residue of sialyl Lewis(X): a molecular orbital study with insights into its binding properties toward the carbohydrate recognition domain of E-selectin.
    Pichierri F; Matsuo Y
    Bioorg Med Chem; 2002 Aug; 10(8):2751-7. PubMed ID: 12057664
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Structure of a selectin-like mutant of mannose-binding protein complexed with sialylated and sulfated Lewis(x) oligosaccharides.
    Ng KK; Weis WI
    Biochemistry; 1997 Feb; 36(5):979-88. PubMed ID: 9033386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synthesis of 1,1-linked galactosyl mannosides carrying a thiazine ring as mimetics of sialyl Lewis X antigen: investigation of the effect of carboxyl group orientation on P-selectin inhibition.
    Shibata K; Hiruma K; Kanie O; Wong CH
    J Org Chem; 2000 Apr; 65(8):2393-8. PubMed ID: 10789451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemoenzymatic synthesis of functional sialyl Lewis(x) mimetics with a heteroaromatic core.
    Schlemmer C; Wiebe C; Ferenc D; Kowalczyk D; Wedepohl S; Ziegelmüller P; Dernedde J; Opatz T
    Chem Asian J; 2014 Aug; 9(8):2119-25. PubMed ID: 24888318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzymatic synthesis of a sialyl Lewis X dimer from egg yolk as an inhibitor of E-selectin.
    Lin CH; Shimazaki M; Wong CH; Koketsu M; Juneja LR; Kim M
    Bioorg Med Chem; 1995 Dec; 3(12):1625-30. PubMed ID: 8770386
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Design and synthesis of a new sialyl Lewis X mimetic: how selective are the selectin receptors?
    De Vleeschauwer M; Vaillancourt M; Goudreau N; Guindon Y; Gravel D
    Bioorg Med Chem Lett; 2001 May; 11(9):1109-12. PubMed ID: 11354355
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis of sialyl Lewis X mimetics using the Ugi four-component reaction.
    Tsai CY; Park WK; Weitz-Schmidt G; Ernst B; Wong CH
    Bioorg Med Chem Lett; 1998 Sep; 8(17):2333-8. PubMed ID: 9873537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Study on selectin blocker. 8. Lead discovery of a non-sugar antagonist using a 3D-pharmacophore model.
    Hiramatsu Y; Tsukida T; Nakai Y; Inoue Y; Kondo H
    J Med Chem; 2000 Apr; 43(8):1476-83. PubMed ID: 10780903
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.